Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Menthol”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,135 records · Page 63Linked to original sources

Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course.

In recent years it has become increasingly evident that the toxicity produced by a variety of compounds can be attributed to their metabolites. Simple dose-toxicity studies of a metabolite will help to elucidate its toxic effect, but it is not possible to quantify its role in the toxicity produced by the parent compound unless the disposition of the preformed and endogenously formed metabolite is taken into account. We assessed the contribution of the metabolite, R-(+)-menthofuran (MF), to the hepatotoxicity observed after i.p. administration of R-(+)-pulegone (PUL) to rats. As the major constituent of pennyroyal oil, PUL has been linked to the deaths of several young women over the past several years. After i.p. administration of PUL and MF to separate groups of rats at doses selected to match the area under the curve of generated and synthetic MF, plasma alanine transferase was comparable between groups. Although the area under the curve was matched, the peak concentration in plasma of MF formed in vivo is 4.5 times higher and occurs much earlier than after the administration of MF itself. When the exposure of rats to preformed and synthetic MF is matched with respect to time course in plasma, PUL produces more than twice the increase in plasma alanine transferase and hepatocellular necrosis than does MF. The results suggest that events other than those associated with the disposition of MF contribute to the hepatotoxicity observed after ingestion of PUL, and they emphasize the importance of time course in assessing the role of a metabolite in the toxicity of a given compound.

Alanine Transaminase↗

Effects of drug metabolism modifiers on pulegone-induced hepatotoxicity in mice.

Intraperitoneal injection of R-(+)-pulegone (pulegone), the main constituent of pennyroyal oil, to ddY mice caused extensive liver injury as characterized by an increase in serum glutamic pyruvic transaminase (GPT) activity and centrilobular necrosis of hepatocytes. Treatments of mice with the cytochrome P-450 enzyme inhibitors, SKF-525A, metyrapone, piperonyl butoxide, and carbon disulfide (CS2), prevented or markedly alleviated the hepatotoxicity of pulegone. These results are compatible with the view that some metabolite of pulegone is responsible for the liver injury in mice.

Animals↗